NO20080741L - Ekstrakter av Ginkgo biloba - Google Patents

Ekstrakter av Ginkgo biloba

Info

Publication number
NO20080741L
NO20080741L NO20080741A NO20080741A NO20080741L NO 20080741 L NO20080741 L NO 20080741L NO 20080741 A NO20080741 A NO 20080741A NO 20080741 A NO20080741 A NO 20080741A NO 20080741 L NO20080741 L NO 20080741L
Authority
NO
Norway
Prior art keywords
ginkgo biloba
extracts
weight
proantocyanidins
ginkgolides
Prior art date
Application number
NO20080741A
Other languages
English (en)
Inventor
Christophe Carite
Santiago Rull Prous
Smail Alaoui Ismaili
Pedro Forner
Christine Gartner
Sybille Buchwald-Werner
Original Assignee
Naturex
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Naturex filed Critical Naturex
Publication of NO20080741L publication Critical patent/NO20080741L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/423—Oxazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Botany (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Medical Informatics (AREA)
  • Nutrition Science (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Nye ekstrakter fra bladene til Ginkgo biloba, omfattende (a) 20 til 30 vekt-% flavonglykosider, 2,5 til 4,5 vekt-% ginkgolider A, B, C og J (totalt), (c) 2,0 til 4,0 vekt-% bilobalider, (d) mindre enn 10 ppm alkylfenolforbindelser og (e) mer enn 10 vekt-% oligomere proantocyanidiner (OPC).
NO20080741A 2005-07-12 2008-02-11 Ekstrakter av Ginkgo biloba NO20080741L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0552158A FR2888509B1 (fr) 2005-07-12 2005-07-12 Extraits de ginkgo biloba
PCT/EP2006/006429 WO2007006443A1 (en) 2005-07-12 2006-07-01 Extracts of ginkgo biloba

Publications (1)

Publication Number Publication Date
NO20080741L true NO20080741L (no) 2008-02-11

Family

ID=35966402

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20080741A NO20080741L (no) 2005-07-12 2008-02-11 Ekstrakter av Ginkgo biloba

Country Status (11)

Country Link
US (1) US20080193572A1 (no)
EP (1) EP1906981A1 (no)
JP (1) JP2009501169A (no)
KR (1) KR20080023733A (no)
CN (1) CN101222929A (no)
AU (1) AU2006268999A1 (no)
BR (1) BRPI0612828A2 (no)
CA (1) CA2615031A1 (no)
FR (1) FR2888509B1 (no)
NO (1) NO20080741L (no)
WO (1) WO2007006443A1 (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010090741A1 (en) * 2009-02-04 2010-08-12 Kalamazoo Holdings, Inc. Compositions and methods for enhancing the stability of foods, beverages, nutritional supplements and cosmetics
JP2013035820A (ja) * 2011-05-10 2013-02-21 Maruzen Pharmaceut Co Ltd Ｔｉｅ２活性化剤、血管新生抑制剤、血管の成熟化剤、血管の正常化剤、及び血管の安定化剤、並びに医薬品組成物
DE102014202318B4 (de) 2014-02-10 2016-10-06 Dr. Willmar Schwabe Gmbh & Co. Kg Verbessertes Verfahren zur Herstellung von Ginkgoextrakten
CN104352538A (zh) * 2014-12-05 2015-02-18 上海信谊百路达药业有限公司 银杏内酯组合物在制备预防/治疗青光眼药物中的应用
CN117731700B (zh) * 2023-12-12 2025-07-22 河北睿济堂中药股份有限公司 一种银杏叶软胶囊及其制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2627387B1 (fr) * 1988-02-24 1992-06-05 Fabre Sa Pierre Procede d'obtention d'un extrait de feuilles de ginkgo biloba
JPH07101850B2 (ja) * 1988-04-08 1995-11-01 日本電信電話株式会社 適応ベクトル量子化法
US5637302A (en) * 1988-09-20 1997-06-10 Indena Spa Extracts of Ginkgo biloba and their methods of preparation
DE3940092A1 (de) * 1989-12-04 1991-06-06 Schwabe Willmar Gmbh & Co Extrakt aus blaettern von ginkgo biloba, verfahren zu seiner herstellung und den extrakt enthaltende arzneimittel
DE19756848C2 (de) * 1997-12-19 2003-01-16 Schwabe Willmar Gmbh & Co Extrakte aus Blättern von Ginkgo biloba mit vermindertem Gehalt an 4'-O-Methylpyridoxin und Biflavonen
CN1073562C (zh) * 1999-02-05 2001-10-24 孙传经 超临界二氧化碳从银杏叶中萃取含有原花青素提取物的方法
DE59912559D1 (de) * 1999-07-02 2005-10-20 Cognis Ip Man Gmbh Mikrokapseln - III
EP1064912B1 (de) * 1999-07-02 2004-01-28 Cognis Iberia, S.L. Mikrokapseln - I
ES2213948T3 (es) * 1999-07-02 2004-09-01 Cognis Iberia, S.L. Microcapsulas ii.
US6979457B2 (en) * 2001-12-28 2005-12-27 Renew Life Formulas, Inc. Food supplement formulation
JP2004123622A (ja) * 2002-10-03 2004-04-22 Toyo Shinyaku:Kk 血流改善外用剤

Also Published As

Publication number Publication date
US20080193572A1 (en) 2008-08-14
FR2888509A1 (fr) 2007-01-19
KR20080023733A (ko) 2008-03-14
AU2006268999A1 (en) 2007-01-18
CN101222929A (zh) 2008-07-16
CA2615031A1 (en) 2007-01-18
BRPI0612828A2 (pt) 2010-11-30
WO2007006443A1 (en) 2007-01-18
FR2888509B1 (fr) 2007-09-14
JP2009501169A (ja) 2009-01-15
EP1906981A1 (en) 2008-04-09

Similar Documents

Publication Publication Date Title
NO20065946L (no) DPP-IV-inhibitorer
NO20054083L (no) Nye sammenkoblede triazoloner og deres anvendelse
NO20082909L (no) Fremgangsmate for a utvinne lignan-ekstrakter og sammensetninger inneholdende lignan-ekstraktene
NO20091710L (no) Scale squeeze behandlingssysystemer og fremgangsmater
WO2004041184A3 (en) Nutraceutical mangosteen composition
WO2008013840A3 (en) Erastin analogs and uses thereof
WO2008017346A3 (de) Ascorbinsäurederivate, verwendung zur funktionalisierung von matrices
NO20070608L (no) Anvendelse av 2-tio-3,5-dicyano-4-fenyl-6-aminopyridiner ved behandling av kvalme og oppkast
ATE519373T1 (de) Teezusammensetzung und herstellungsverfahren dafür
NO20070390L (no) Triterpen-inneholdende oleogel-dannende middel, triterpen-inneholdende oleogel og fremgangsmate for fremstilling av en triterpen-inneholdende oleogel
TW200732296A (en) Novel compounds
DE60325265D1 (de) Antioxidative zusammensetzungen
TW200638874A (en) Use of tetramic acid derivatives for controlling insects from the genus of the plant lice (sternorrhyncha)
CR9079A (es) Nonadepsipeptidos acilados como derivados de lisobactina
MY166022A (en) Long-lasting absorption of flavonoids
WO2005027963A3 (en) METHODS AND COMPOSITIONS FOR THE GENERATION OF A PROTECTIVE IMMUNE RESPONSE AGAINTS SARS-CoV
AR065979A1 (es) Formas solidas de la oxima de la (e) - 1-(4 - ( (1r,2s,3r) - 1,2,3,4, - tetrahidroxibutil) - 1h - imidazol - 2 - il) etanona
DK1965809T3 (da) Præparater til forbedring af sundhedstilstanden i dyrs tarmsystem og dyrs ydeevne omfattende Beta-glucanerne og Alfa-fucaner
ATE444990T1 (de) Spritzbare akustikmassen
TW200700071A (en) Novel use
TW200745039A (en) Isotopically substituted pantoprazole
NO20080515L (no) Aktiv fraksjon fra et polart losningsmiddelekstrakt fra lates fra euphoribiaceae-plantene
NO20074528L (no) Substituerte pyrroler, sammensetninger, fremgangsmate for fremstilling og anvendelse av samme
UA94080C2 (ru) Ациклически-замещенные производные фуропиримидина и их применение для лечения сердечно-сосудистых заболеваний
WO2006083366A3 (en) Preparation of ginkgolide and f-seco-ginkgolide lactols

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application